Insulet Corp (PODD)
187.27
+1.89
(+1.02%)
USD |
NASDAQ |
May 17, 16:00
187.38
+0.11
(+0.06%)
After-Hours: 20:00
Insulet Free Cash Flow: 136.70M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 136.70M |
| December 31, 2023 | 36.50M |
| September 30, 2023 | -14.80M |
| June 30, 2023 | -25.60M |
| March 31, 2023 | -45.30M |
| December 31, 2022 | -38.30M |
| September 30, 2022 | -63.00M |
| June 30, 2022 | -140.80M |
| March 31, 2022 | -151.90M |
| December 31, 2021 | -190.80M |
| September 30, 2021 | -199.10M |
| June 30, 2021 | -126.50M |
| March 31, 2021 | -120.00M |
| December 31, 2020 | -82.50M |
| September 30, 2020 | -14.80M |
| June 30, 2020 | -25.40M |
| March 31, 2020 | -64.70M |
| December 31, 2019 | -72.50M |
| September 30, 2019 | -73.90M |
| June 30, 2019 | -102.67M |
| March 31, 2019 | -125.66M |
| December 31, 2018 | -126.50M |
| September 30, 2018 | -129.59M |
| June 30, 2018 | -93.29M |
| March 31, 2018 | -28.03M |
| Date | Value |
|---|---|
| December 31, 2017 | -35.90M |
| September 30, 2017 | -11.25M |
| June 30, 2017 | -36.40M |
| March 31, 2017 | -40.04M |
| December 31, 2016 | -6.204M |
| September 30, 2016 | -45.44M |
| June 30, 2016 | -28.60M |
| March 31, 2016 | -29.00M |
| December 31, 2015 | -23.16M |
| September 30, 2015 | 0.891M |
| June 30, 2015 | -3.616M |
| March 31, 2015 | -7.226M |
| December 31, 2014 | -2.566M |
| September 30, 2014 | -10.85M |
| June 30, 2014 | -10.69M |
| March 31, 2014 | -4.864M |
| December 31, 2013 | -3.959M |
| September 30, 2013 | -5.299M |
| June 30, 2013 | -15.31M |
| March 31, 2013 | -31.72M |
| December 31, 2012 | -40.05M |
| September 30, 2012 | -42.35M |
| June 30, 2012 | -38.32M |
| March 31, 2012 | -36.40M |
| December 31, 2011 | -36.57M |
Free Cash Flow Range, Past 5 Years
-199.10M
Minimum
Sep 2021
136.70M
Maximum
Mar 2024
-68.97M
Average
-68.60M
Median
Free Cash Flow Benchmarks
| Stryker Corp | 2.858B |
| Tandem Diabetes Care Inc | -66.71M |
| Abbott Laboratories | 4.923B |
| ResMed Inc | 1.071B |
| Integra Lifesciences Holdings Corp | 60.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 87.60M |
| Cash from Investing (Quarterly) | -24.00M |
| Cash from Financing (Quarterly) | -14.10M |
| Free Cash Flow Per Share (Quarterly) | 0.8625 |
| Free Cash Flow to Equity (Quarterly) | 77.90M |
| Free Cash Flow to Firm (Quarterly) | 64.82M |
| Free Cash Flow Yield | 0.97% |